Evidence map›Paper›PMID 27409293›Full record

ReviewHuman vaccines & immunotherapeutics2016

Immunization of HIV-infected adult patients - French recommendations.

Anne Frésard, Amandine Gagneux-Brunon, Frédéric Lucht, Elisabeth Botelho-Nevers, Odile Launay

Abstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anne Frésarda Department of Infectious Diseases , CHU Saint-Etienne , Saint-Etienne , France.
Amandine Gagneux-Brunona Department of Infectious Diseases , CHU Saint-Etienne , Saint-Etienne , France.
Frédéric Luchta Department of Infectious Diseases , CHU Saint-Etienne , Saint-Etienne , France.
Elisabeth Botelho-Neversa Department of Infectious Diseases , CHU Saint-Etienne , Saint-Etienne , France.
Odile Launayc Inserm, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC) , Paris , France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human immunodeficiency virus (HIV)-infected patients remain at increased risk of infection including vaccine-preventable diseases. Vaccines are therefore critical components in the protection of HIV-infected patients from an increasing number of preventable diseases. However, missed opportunities for vaccination among HIV-infected patients persist and vaccine coverage in this population could be improved. This article presents the French recommendations regarding immunization of HIV-infected adults in the light of the evidence-based literature on the benefits and the potential risks of vaccines among this vulnerable population.

Indexed as

AdultFranceHealth PolicyHIV InfectionsHumansImmunizationHIV infectionimmunizationimmunocompromised patientsinfluenzalive vaccinespneumococcal infectionsrecommendationsvaccinevaccine-preventable diseases

Identifiers

PMID27409293
PMCPMC5137523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.